ViiV's injection still suppresses HIV when taken every two m...

GSK’s ViiV Healthcare joint venture has announced data backing an injection taken that can suppress the HIV virus even if it is taken only six times a year, instead of every month.

Gilead will challenge US government patent on PrEP drug Truv...

Gilead’s Descovy gets FDA panel OK for PrEP, but not for wom...

FDA reviewer backs Gilead’s Descovy for PrEP, but not in wom...

Gilead ups forecasts as new HIV drug boosts sales

Gilead has become the latest pharma company to raise its full year sales forecasts following stronger than expected Q2 results.

ViiV files monthly HIV jab in Europe